Effect of Tigulixostat on the Pharmacokinetics of Theophylline

See also
Status	Clinical Trial	Phase
Completed	`NCT04060173` - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671	Phase 1
Not yet recruiting	`NCT06187519` - UR+AIMS Gout Wearable Skin Uric Acid Monitor Study	N/A
Completed	`NCT03635957` - Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout	Phase 4
Completed	`NCT04966325` - Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects	Early Phase 1
Completed	`NCT03015948` - A Single Dose Study of SHR4640 in Healthy Male Volunteers	Phase 1
Completed	`NCT02855437` - Novel Methods for Ascertainment of Gout Flares -A Pilot Study	N/A
Active, not recruiting	`NCT02702375` - Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases	N/A
Completed	`NCT01407874` - A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency	Phase 2
Completed	`NCT00995618` - Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia	Phase 2
Completed	`NCT00985127` - Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout	Phase 2
Terminated	`NCT04987294` - Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease	Phase 2
Completed	`NCT03291782` - D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers	Phase 1
Recruiting	`NCT03388515` - A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.	Phase 1
Enrolling by invitation	`NCT03336203` - The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)	Phase 4
Recruiting	`NCT05586958` - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients	Phase 3
Recruiting	`NCT04047394` - A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers	Phase 1
Not yet recruiting	`NCT05507723` - Tight Control of Gouty Arthritis Compared to Usual Care	N/A
Recruiting	`NCT06056570` - Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia	Phase 1/Phase 2
Completed	`NCT02557126` - Study of URC102 to Assess the Safety and Efficacy in Gout Patients	Phase 2
Completed	`NCT02246673` - RDEA3170 and Febuxostat Combination Study in Gout Subjects	Phase 2

NCT number	NCT06189404
Study type	Interventional
Source	LG Chem
Contact
Status	Completed
Phase	Phase 1
Start date	October 31, 2023
Completion date	November 30, 2023

Effect of Tigulixostat on the Pharmacokinetics of Theophylline

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms